P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMA
Chris Meulenbroeks(Princess Máxima Center), M Kool(German Cancer Research Center), Nzinga Mack(German Cancer Research Center), Benjamin Schwalm(German Cancer Research Center), Phylicia Stathi(Princess Máxima Center), Mariëtte E.G. Kranendonk(Princess Máxima Center), Stefan M. Pfister(Heidelberg University), C. Giebel(Princess Máxima Center), Eelco W. Hoving(Princess Máxima Center), Sabine Plasschaert(Princess Máxima Center), Marc van de Wetering(Oncode Institute), Neal Geisemeyer(German Cancer Research Center), Jens Bunt(Princess Máxima Center)
Cited by 0
Related Papers
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
|Cell|2002|2k
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
|Nature|2013|1.6k
Lgr5+ve Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro
|Cell stem cell|2010|1.5k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k